tiprankstipranks
Trending News
More News >
Circassia Pharmaceuticals (GB:NIOX)
:NIOX
UK Market

Circassia Pharmaceuticals (NIOX) Income Statement

Compare
13 Followers

Circassia Pharmaceuticals Income Statement

Last quarter (Q4 2024), Circassia Pharmaceuticals's total revenue was £20.80M, an increase of 31.65% from the same quarter last year. In Q4, Circassia Pharmaceuticals's net income was £-700.00K. See Circassia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 41.80M£ 36.80M£ 31.30M£ 27.90M£ 23.90M
Gross Profit
£ 30.20M£ 26.50M£ 22.20M£ 19.00M£ 16.30M
Operating Expenses
£ 22.50M£ 21.90M£ 20.40M£ 23.30M£ 33.60M
Depreciation and Amortization
£ 4.20M£ 4.40M£ 4.60M£ 4.90M£ 9.00M
EBITDA
£ 12.20M£ 8.60M£ 15.20M£ 2.90M£ -9.10M
Operating Income
£ 7.70M£ 4.60M£ 1.80M£ -4.30M£ -17.30M
Other Income/Expenses
£ 100.00K£ -500.00K£ 8.70M£ 2.20M£ -1.10M
Pretax Income
£ 7.80M£ 4.10M£ 10.50M£ -2.10M£ -18.40M
Net Income
£ 3.70M£ 10.70M£ 16.10M£ 3.60M£ -33.50M
Per Share Metrics
Basic EPS
£ 0.01£ 0.03£ 0.04£ 0.01£ -0.09
Diluted EPS
£ 0.01£ 0.02£ 0.04£ 0.01£ -0.09
Weighted Average Shares Outstanding
418.21M 420.20M 419.20M 412.61M 381.86M
Weighted Average Shares Outstanding (Diluted)
448.21M 449.28M 443.00M 435.83M 381.86M
Currency in GBP

Circassia Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis